Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown it more than 500 employees, is to step down from his role now that his company has been acquired by Celgene in a $9 billion deal earlier this year, it has emerged.
Ook interessant voor je
Reageer